SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS)
Clinical trials for SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS) explained in plain language.
Never miss a new study
Get alerted when new SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS) trials appear
Sign up with your email to follow new studies for SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for progressive MS: phase 3 trial of remibrutinib launches
Disease control Recruiting nowThis study tests whether the drug remibrutinib can slow disability worsening in people with secondary progressive multiple sclerosis (SPMS). About 1,275 adults aged 18-65 with SPMS will receive either the drug or a placebo. The main goal is to see if remibrutinib delays confirmed…
Matched conditions: SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS)
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 06:18 UTC
-
Can a cancer drug sharpen the mind and hands in advanced MS?
Disease control Recruiting nowThis study tests whether the drug rituximab can improve memory, thinking speed, and hand function in people with advanced secondary progressive multiple sclerosis (SPMS). About 46 participants with high disability will receive either rituximab or a placebo for one year. Researche…
Matched conditions: SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS)
Phase: PHASE2 • Sponsor: Cairo University • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
New cell therapy TRX319 aims to slow progressive MS
Disease control Recruiting nowThis early-stage trial tests TRX319, a cell therapy, in 39 adults with primary or secondary progressive MS. The goal is to see if it is safe, find the best dose, and check if pre-treatment with another drug helps it work. Participants receive up to 3 doses over a year and undergo…
Matched conditions: SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS)
Phase: PHASE1, PHASE2 • Sponsor: Tr1X, Inc. • Aim: Disease control
Last updated May 04, 2026 16:21 UTC